IRVINE, Calif., Feb. 28 /PRNewswire/ -- Masimo(R), the inventor of
Read-Through Motion & Low Perfusion Pulse Oximetry, today announced the next
breakthrough in the world of noninvasive patient monitoring; Masimo
Rainbow(TM) SET Pulse CO-Oximetry(TM). Masimo Rainbow SET employs
revolutionary sensor, hardware and software designs that are able to collect
more information noninvasively than previously believed possible. With the
introduction of Masimo SET(R) (Signal Extraction Technology) in 1996, Masimo
solved the problem clinicians faced with inaccuracy and false alarms
associated with pulse oximetry due to patient motion, low perfusion and other
challenging conditions. Now, with Masimo Rainbow SET, Masimo ushers a new era
where carbon monoxide and potentially other vital parameters can be safely and
accurately monitored continuously and noninvasively.
Rainbow technology is based on system theory and adaptive signal
processing algorithms first introduced to the medical community with Masimo
SET in 1996. Rainbow technology goes further with the ability to analyze
information from a sophisticated new sensor technology that employs eight
wavelengths. The Rainbow sensor generates an extraordinarily rich
physiological data stream, which opens the door to monitoring additional
parameters that presently require costly, inconvenient blood gas measurements
that are often unavailable when the information is needed most.
In addition to Rainbow SET's current ability to noninvasively monitor the
level of carbon monoxide in the blood, Masimo's engineering team is utilizing
the additional data delivered by the Rainbow technology platform and sensors
to qualify and document an array of new potential measurements and
applications. The Masimo Rainbow SET platform has been developed with the
intent to deliver accurate monitoring of parameters like methemoglobin
(SpMet(TM)), and fractional arterial oxygen saturation (SpaO2(TM)), all
The first product built with Rainbow technology, Rad-57(TM), will be
debuted March 19 at the 2005 EMS Today convention in Philadelphia. The Rad-57
is a handheld Signal Extraction Pulse CO-Oximeter(TM) that noninvasively
measures the percentage of hemoglobin bound with carbon monoxide (SpCO(TM)).
In the past, accurate measurement of carbon monoxide in the body required
invasive procedures, and simply was not practical in most emergency situations
where it is often needed. The Rad-57 will provide all clinicians and
emergency workers reliable information on carbon monoxide poisoning in
seconds, enabling timely decisions on appropriate treatment. Besides SpCO,
the Rad-57 also measures SpO2, perfusion index and pulse rate utilizing Masimo
SET pulse oximetry, with its proven ability to read through motion and low
perfusion. Rad-57 utilizes MX-1(TM), the new Masimo Rainbow SET Pulse
CO-Oximetry OEM platform. Masimo will make MX-1 available to its OEM partners
who wish to provide Pulse CO-Oximetry to their customers.
"Ten years ago, Masimo broke new ground by making pulse oximeters reliable
during motion and low perfusion, using their Signal Extraction Technology.
Masimo will advance pulse oximetry again with their new Rainbow technology.
In the 25-year history of pulse oximetry, no one has produced an instrument
that will function accurately on patients suffering from carbon monoxide
poisoning," reports Dr. Steven Barker, Head of the Department of
Anesthesiology at the University of Arizona College of Medicine. "As shown in
my studies on animals (Anesthesiology 66:677-79, 1987), conventional pulse
oximeters cannot distinguish between oxygenated hemoglobin and
carboxyhemoglobin, falsely reporting both as oxygenated. Since
carboxyhemoglobin is a toxic form that can cause death at levels greater than
50%, the development of a pulse oximeter that can separately measure
carboxyhemoglobin and oxyhemoglobin will be a major advance in healthcare.
Such a device would soon become a standard of care in emergency rooms,
ambulances, and many other critical care settings."
Joe E. Kiani, CEO of Masimo stated, "Solving unsolvable problems has been
the driving force behind Masimo's culture and mission. Our mission has been
to Improve Patient Care and Reduce Cost of Care by Taking Noninvasive Patient
Monitoring to New Sites and Applications. Masimo and Masimo Labs engineering
team have been working for years to introduce the Rainbow platform. Rainbow
represents a new era in noninvasive monitoring, and we are eager to deliver
these new solutions that we know can save lives and improve outcomes for so
many patients. We are proud to once again introduce the next evolution of
Beginning in March, all Masimo Radical pulse oximeters will be shipped
"Rainbow Ready." Rainbow Ready Radical oximeters include Masimo SET
technology; and will permit customers to add Rainbow-specific parameters such
as SpCO and additional potential parameters via simple software upgrade
options. In addition, Masimo is creating a Rainbow upgrade program to allow
its customers who purchased Radicals prior to the availability of this new
platform to economically upgrade to Rainbow SET Pulse CO-Oximetry. Customers
should contact their Masimo representative for complete details. In the
months ahead, Masimo will introduce Rainbow SET compatibility in other new
Masimo, founded in 1989, is the inventor and leader of Signal Extraction
Pulse CO-Oximetry. Masimo develops, licenses, and markets advanced medical
signal processing technologies and products for the non-invasive monitoring of
vital signs. Masimo Signal Extraction Technology, or Masimo SET, represents
the standard of care for pulse oximeters. With its introduction in 1996,
Masimo SET overcame data dropouts, false alarms and inaccurate measurements
due to patient motion, low perfusion and other challenging conditions. Over
100 clinical studies support the conclusion that Masimo SET is the most
effective pulse oximeter in the world.
With the advent of Rainbow Technology, Masimo ushers a new era for
noninvasive monitoring, where patients at risk of respiratory and cardiac
complications, carbon monoxide poisoning and other life threatening diseases
can be safely, noninvasively and accurately monitored with Pulse CO-Oximetry.
Masimo is headquartered in Irvine, California. Additional information about
Masimo and its products can be found at www.masimo.com.
Masimo, Signal Extraction Technology, SET, Radical and Rad are registered
trademarks of Masimo Corporation. Signal Extraction, Rad-57 and MX-1 are
trademarks of Masimo Corporation. Rainbow, Pulse CO-Oximetry, Pulse
CO-Oximeter, SpCO, SpMet, and SpaO2 are trademarks of Masimo Laboratories.
SOURCE Masimo Corporation